andYSDOSLung CancerTsukada H, Yokoyama A, Kurita Y, Isobe H, Watanabe K, Saijyo N. Phase I=II trial of Cisplatin(CDDP), Etoposide(ETP), and Irinotecan(CPT-II) for the treatment of advanced non-small-cell lung cancer(NSCLC): Japan Clinical Oncology Group(JCOG) study 9512. American ...
Phase I/II trial of cisplatin (CDDP), etoposide (ETP), and irinotecan (CPT-11) for the treatment of advanced non-small-cell lung cancer (NSCLC). Japan Clin... Irinotecan (CPT-11) has been shown to exhibit excellent antitumour activity against small-cell lung cancer (SCLC). A multi-ins...